Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

FROM SAVING INDIVIDUAL LIVES TO BUILDING A NATIONAL ECMO NETWORK: VIETNAM’S NEXT CRITICAL CARE MILESTONE

11/07/2026 Published by PhamTuThu

Not every healthcare breakthrough comes from a new drug or a breakthrough medical device. Sometimes, the greatest impact comes from... Read more

Tags: #Vietnam

WHY THE MERGER OF BAC TAN UYEN REGIONAL MEDICAL CENTER COULD SIGNAL A NEW DIRECTION FOR VIETNAM’S PUBLIC HEALTHCARE SYSTEM

11/07/2026 Published by PhamTuThu

Not every healthcare reform begins with the construction of a new hospital. Sometimes, it begins with a decision to reorganize... Read more

Category: Uncategorized

Tags: #M&A

More Than a New Therapy: Vietnam’s Hyperkalemia Breakthrough Reshapes Cardiorenal Care

11/07/2026 Published by PhamTuThu

Executive Summary Vietnam has expanded access to sodium zirconium cyclosilicate (SZC), a next-generation oral potassium binder for hyperkalemia, through the... Read more

Category: Uncategorized

Tags: #Vietnam

Europe Moves Bispecific Antibodies Earlier in Follicular Lymphoma Care as AbbVie Secures New Regulatory Milestone

11/07/2026 Published by PhamTuThu

Key Development The European Commission has approved AbbVie and Genmab's bispecific antibody TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab... Read more

Category: Uncategorized

Tags: #Global Trends

WHEN PROMISING SCIENCE ISN’T ENOUGH: ASTRAZENECA’S PHASE III SETBACK REDEFINES THE ATTR-CM RACE

10/07/2026 Published by PhamTuThu

Key Development AstraZeneca and Ionis Pharmaceuticals announced that a late-stage clinical trial evaluating eplontersen for transthyretin amyloid cardiomyopathy (ATTR-CM) failed... Read more

Category: Uncategorized

Tags: #Global Trends

VIETNAM’S NEXT HEALTHCARE FRONTIER: BUILDING A STRATEGIC VACCINE INNOVATION ECOSYSTEM

10/07/2026 Published by PhamTuThu

Key Development Vietnam is entering a new phase in its healthcare development strategy by accelerating investment in next-generation vaccine manufacturing.... Read more

Category: Uncategorized

Tags: #Vietnam

CHINA’S ESSENTIAL MEDICINE LIST SIGNALS A NEW ERA FOR GLP-1 ACCESS FROM PREMIUM THERAPY TO NATIONAL HEALTHCARE INFRASTRUCTURE

10/07/2026 Published by PhamTuThu

Key Development China has taken another significant step in reshaping diabetes care by adding semaglutide, the second GLP-1 receptor agonist... Read more

Category: Uncategorized

Tags: #Global Trends